Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

Nature Medicine
Y IsakaW A Border

Abstract

There are currently no effective therapies for progressive fibrotic diseases. Recent evidence has implicated overproduction of transforming growth factor-beta1 (TGF-beta1) as a major cause of tissue fibrosis. Furthermore, this evidence implies that inhibitors of TGF-beta1 may be clinically useful as antifibrotic agents. The proteoglycan decorin is a known inhibitor of TGF-beta1. In a rat model of glomerulonephritis we have shown that fibrosis is mediated by TGF-beta1. We report here that transfer of decorin cDNA into rat skeletal muscle increases the amount of decorin messenger RNA and protein present in skeletal muscle and decorin present in kidney, where it has a marked therapeutic effect on fibrosis induced by glomerulonephritis. Transfected glomerulonephritic rats showed a significant reduction in levels of glomerular TGF-beta1 mRNA and TGF-beta1 protein, extracellular matrix accumulation and proteinuria. These results demonstrate the potential of gene therapy as a novel treatment for fibrotic diseases caused by TGF-beta1.

References

Dec 1, 1992·The Journal of Cell Biology·M B Sporn, A B Roberts
Jan 1, 1992·Progress in Growth Factor Research·N A NobleW A Border
Mar 23, 1990·Science·J A WolffP L Felgner
Mar 8, 1991·Cell·E Ruoslahti, Y Yamaguchi
Oct 1, 1995·Nature Medicine·W A Border, N A Noble
Aug 1, 1995·The Journal of Clinical Investigation·W A Border, N A Noble
Aug 25, 1995·Science·E Marshall
Dec 1, 1994·Vaccine·I Danko, J A Wolff
Nov 10, 1994·The New England Journal of Medicine·W A Border, N A Noble
Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·S K TripathyJ M Leiden
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E RazD A Carson

❮ Previous
Next ❯

Citations

Jul 12, 2002·Journal of Clinical Laboratory Analysis·Antonia CostacurtaSalvatore Cantaro
Jan 31, 2006·Journal of Physiology and Biochemistry·M PrietoN Eleno
May 29, 2007·Zeitschrift für Rheumatologie·N HunzelmannS Rosenkranz
Jul 8, 2011·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Khaled NassarSalvatore Grisanti
Nov 29, 2005·Journal of Human Genetics·Aritoshi IidaShiro Ikegawa
Sep 19, 2008·Current Gastroenterology Reports·Mohammed A Qadeer, John J Vargo
Oct 3, 2003·Biochemical and Biophysical Research Communications·Rachel A Page, Afshan N Malik
May 19, 2004·The International Journal of Biochemistry & Cell Biology·Eiko Honda, Hiroshi Munakata
Jun 7, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Toshihiro KushibikiYasuhiko Tabata
Jun 14, 2005·Matrix Biology : Journal of the International Society for Matrix Biology·Sara M WeisAndrew D McCulloch
Jan 17, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Pierina De MuroGian Mario Cherchi
May 22, 2003·The American Journal of Pathology·Sunfa Cheng, David H Lovett
Mar 14, 2002·The American Journal of Pathology·Manolis Mavroidis, Yassemi Capetanaki
Jun 8, 2000·Clinica Chimica Acta; International Journal of Clinical Chemistry·M OtsA Tamm
Jan 6, 1999·Journal of Hepatology·T HiranoY Kaneda
Jul 11, 2002·Biochimie·Koji YoshidaHiroshi Munakata
Sep 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Zahid N RabbaniZeljko Vujaskovic
Jun 12, 2001·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·N FukuiK Nakamura
Dec 5, 2000·Matrix Biology : Journal of the International Society for Matrix Biology·A MarkmannH Kresse
Jul 11, 2003·Matrix Biology : Journal of the International Society for Matrix Biology·Ayman Al Haj ZenBruno Gogly
Aug 7, 2003·Seminars in Radiation Oncology·Brian O'Sullivan, Wilfred Levin
May 1, 1998·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·S C Tyagi
Dec 28, 1999·Microbes and Infection·M H Branton, J B Kopp
Dec 28, 1999·Microbes and Infection·G S Ashcroft
Jan 1, 1997·The International Journal of Biochemistry & Cell Biology·S O'Kane, M W Ferguson
Jan 1, 1997·The International Journal of Biochemistry & Cell Biology·T J Franklin
Apr 16, 2002·Current Opinion in Pharmacology·Ling YuWayne A Border
Feb 11, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Don C Rockey
May 4, 2000·The New England Journal of Medicine·G C BlobeH F Lodish

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.